Bipartisan 'Freedom to Heal Act' would open Right to Try access to psilocybin and MDMA

U.S. Congress (Freedom to Heal Act) — Senators Cory Booker and Rand Paul, with House companions Madeleine Dean and Nancy Mace, introduced the Freedom to Heal Act, which would create a DEA-regulated physician registration process allowing patients with severe, life-threatening conditions to access Schedule I 'eligible investigational drugs' such as MDMA and psilocybin under the federal Right to Try framework.

To qualify, a drug must have completed Phase 1 trials. The bill signals continued federal momentum on psychedelic access for veterans and terminally ill patients.

Source: booker.senate.gov

For the rest of that week's sector news, read our week in review.